Skip to main content
SpringerLink
Log in

Could Hormones Make a Difference in the Treatment of Juvenile Rheumatoid Arthritis?

  • Leading Article
  • Published:
BioDrugs Aims and scope Submit manuscript

Abstract

Adrenal androgens dehydroepiandrosterone (DHEA; prasterone) and its sulphated form (DHEA-S) are among the most abundant hormonal steroids in men and nonpregnant women. Deficiencies of these adrenal androgens are associated with autoimmune disorders such as rheumatoid arthritis (RA). Recent studies from our laboratory have also identified low levels of adrenal androgens in the serum and synovial fluid of patients with juvenile rheumatoid arthritis (JRA). These findings support and complement those already published for RA and other autoimmune diseases.

Because of the paucity of data on the hormonal status of patients with JRA, studies on the relationship between hypoandrogenicity and predisposition to develop JRA, and/or disease progression have not been conducted. In addition, despite the rapid expansion of research in the clinical use of these adrenal androgens in hyperlipidaemia, atherosclerosis, obesity, diabetes mellitus, insulin resistance and hypertension, their potential beneficial effects in JRA/RA have not been fully investigated. In fact, clinical trials of adrenal androgens in RA have only been conducted for the treatment of systemic lupus erythematosus.

Further studies using prospective approaches are necessary to provide a unified consensus on the hormonal status of patients with JRA (as well as those with RA). This overview of our knowledge of the putative role(s) of hormones in arthritis will hopefully stimulate researchers in basic science and rheumatologists to synergistically collaborate in the effective translation of such knowledge to new clinical approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. Spector TD, Rheumatoid arthritis. Rheum Dis Clin North Am 16(3): 513–537, 1990

    PubMed  CAS  Google Scholar 

  2. Butterworth MB, McClelan B, Alansmith M. Influence of sex on immunoglobulin levels. Nature 1967; 214: 1224–8

    Article  PubMed  CAS  Google Scholar 

  3. London WT, Drew JR. Antibody responses to hepatitis B infection among patients receiving chronic dialysis treatment. Pro Nat Acad Sci U S A 1977; 74: 2561–3

    Article  CAS  Google Scholar 

  4. Sthoeger ZN, Chiorazzi RG, Lahita RG. Regulation of immune response by sex steroids. J Immunol 1988; 141: 91–8

    PubMed  CAS  Google Scholar 

  5. Schuurs AWHM, Verheul HAM. Effect of gender and sex steroids on the immune response. J Steroid Biochem 1990; 35: 157–72

    Article  PubMed  CAS  Google Scholar 

  6. Daniel L, Souweine G, Monier JC, et al. Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem 1983; 18: 559–63

    Article  Google Scholar 

  7. Cohen JHM, Danel I, Cordier G, et al. Steroid hormone receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8+ cells. J Immunol 1983; 131: 2767–71

    PubMed  CAS  Google Scholar 

  8. Stimson WH. Oestrogen and human lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scan J Immunol 1998 28(3): 345–50

    Article  Google Scholar 

  9. Cutolo M, Accardo S, Villaggio B, et al. Presence of estrogen binding sites on macrophagelike synoviocytes and CD8+, CD29+, CD45+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum 1993; 36: 1087–97

    Article  PubMed  CAS  Google Scholar 

  10. Fox HS, Bond BL, Parslow TG. Estrogen regulates the INFy promoter. J Immunol 1991; 146: 4362–67

    PubMed  CAS  Google Scholar 

  11. Holdstock G, Chastenay B, Krawitt EL. Effects of testosterone, estradiol and progesterone on immune regulation. Clin Exp Immunol 1982; 47: 449–56

    PubMed  CAS  Google Scholar 

  12. Daynes RA, Dudley D, Araneo BA. Regulation of murine lymphokine production in vivo: IV. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by helper T cells. Eur J Immunol 1990; 19: 2319–21

    Article  Google Scholar 

  13. Gilmore W, Weiner LP, Correale J. Effect of E on cytokine secretion by proteolipid proteinspecific T cell clones isolated from multiple sclerosis and normal control subjects. J Immunol 1997; 158: 446–51

    PubMed  CAS  Google Scholar 

  14. Budd RC, Cerottini JC, Macdonald HR. Selectively increased production of INF-γ by subsets of Lyl-2+ and L3T4 T cells identified by expression of Pgp-1. J Immunol 1987; 138: 3583–9

    PubMed  CAS  Google Scholar 

  15. Paavonen T, Anderson LC, Adlecruetz H. Sex hormone regulation of in vivo immune response: estradiol enhances human B cell maturation via inhibition of suppressor T cells in poke-weed mitogen stimulated cultures. J Exp Med 1985; 154: 1935–45

    Article  Google Scholar 

  16. Smithson G, Couse JF, Lubahn DB, et al. The role of estrogen receptors and androgen receptors in sex steroid regulation of B-lymphopoiesis. J Immunol 1998; 161: 27–34

    PubMed  CAS  Google Scholar 

  17. Erben GR, Raith S, Eberle J, et al. Ovariectomy augments B-lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 1998; 274: 476–83

    Google Scholar 

  18. Ushiyama T, Inoue K, Nishioka J. Expression of estrogen related protein and estradiol binding in human arthritic synovium. J Rheumatol 1995; 22: 421–6

    PubMed  CAS  Google Scholar 

  19. Barak V, Maimovitz A, Weinsteind D, et al. The effect of estradiol on human myelomonocytic cells. Enhancement of colony formation. J Reprod Immunol 1985; 7: 325–35

    Article  PubMed  Google Scholar 

  20. Boorman GA, Luster MI, Dean JH, et al. The effect of adult exposure to diethylbestrol in the mouse macrophage function and numbers. J Reticuloendothel Soc 1980; 28: 547–9

    PubMed  CAS  Google Scholar 

  21. Schreiber AD, Nettl F, Sanders MC, et al. Effect of endogenous and synthetic sex steroids on the clearance of antibody coated cells. J Immunol 1988; 141: 2959–66

    PubMed  CAS  Google Scholar 

  22. Hu SK, Mitcho YL, Rath NC. Effect of estradiol on IL-1β synthesis by macrophages. Int J Immunopharmacol 1988; 10: 247–52

    Article  PubMed  CAS  Google Scholar 

  23. Cutolo M, Sulli A, Seriolo B, et al. Estrogen, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13: 217–26

    PubMed  CAS  Google Scholar 

  24. Buyon JP, Korchak HM, Rutherford LE, et al. Female hormone reduce neutrophil responsiveness in vitro. Arthritis Rheum 1984; 27: 623–30

    Article  PubMed  CAS  Google Scholar 

  25. Knauthe R, Diel P, Hegele-Hartung Q et al. Sexual dimorphism of steroid hormone receptor messenger RNA expression and hormonal regulation in rat vascular tissue. Endocrinology 1996; 137: 3220–7

    Article  PubMed  CAS  Google Scholar 

  26. Bhalla RC, Toth KF, Bhatty RA, et al. Estrogen reduces proliferation and agonist-induced Ca increase in coronary artery smooth muscle cells. Am J Physiol 1997; 272: H1996–H2003

    PubMed  CAS  Google Scholar 

  27. Cid MC, Kleinman HK, Grant DS, et al. Estradiol enhances leukocyte binding to TNFα-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, ICAM-1 and VCAM-1. J Clin Invest 1994; 93: 17–25

    Article  PubMed  CAS  Google Scholar 

  28. Aziz KE, Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell Immunol 1996; 167: 79–85

    Article  PubMed  CAS  Google Scholar 

  29. Spyridopoulos I, Sullivan AB, Kearney M, et al. Estrogen-receptor mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997; 95: 1505–14

    Article  PubMed  CAS  Google Scholar 

  30. Sobel MI, Winkel CA, Macy LB, et al. The regulation of plasminogen activator and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obs Gyn 1980; 173: 801–8

    Article  Google Scholar 

  31. Lousink M, Koolwijk P, Van Hinsberg V, et al. Effect of steroid hormones and retinioic acid on capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood 1998; 92: 927–38

    Google Scholar 

  32. Banerjee SK, Campbell DR, Weston AP, et al. Biphasic estrogen response on bovine adrenal medula capillary endothelial cell adhesion, proliferation and tube formation. Mol Cell Biochem 1997; 177: 97–105

    Article  PubMed  CAS  Google Scholar 

  33. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroid on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993; 11: 157–62

    PubMed  CAS  Google Scholar 

  34. Cutolo M, Accardo S, Villaggio B, et al. Cultures synovial macrophages from RA synovium metabolize testosterone and exhibit inhibition of II-1 production. Arthritis Rheum 1993; 36: sl58

    Article  Google Scholar 

  35. Cutolo M. The role of steroid hormones in arthritis. Br J Rheum 1998; 37: 597–601

    Article  CAS  Google Scholar 

  36. Rook GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of Th1/Th2 balance. Immunol Today 1994; 135: 301–3

    Article  Google Scholar 

  37. Bellido T, Jilka R, Boyce B, et al. Regulation of IL-6 osteoclastogenesis and bone mass by androgens. J Clin Invest 1995 95: 2886–95

    Article  PubMed  CAS  Google Scholar 

  38. Keller T, Chang C, Ershler WB. Inhibition of NFkB activity through maintenance of IkB levels contribute to DHEA-mediated repression of IL-6 promoter. J Biol Chem 1996; 271: 26267–75

    Article  PubMed  CAS  Google Scholar 

  39. Bebo Jr BF, Schuster JC, Vandenbark AA, et al. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999; 162: 35–40

    PubMed  CAS  Google Scholar 

  40. Hum DW, Miller WL. Transcriptional regulation of human genes for steroidogenic enzymes. Clin Chem 1993; 39: 333–40

    PubMed  CAS  Google Scholar 

  41. Black SM, Harikrishna JA, Szklarz GD, et al. Mitochondrial environment is required for activity of the cholesterol sidechain cleavate enzyme, cytochrome P450SCC Proc Nat Acad Sci USA 1994; 91: 7247–51

    Article  PubMed  CAS  Google Scholar 

  42. Shealy CN. A review of dehydroepiandrosterone. Integ Physiol Beh Sci 1995; 30: 308–13

    Article  CAS  Google Scholar 

  43. Abraham G, Chekmakjian Z. Plasma steroids in hirsutism. Obsetr Gynecol 1974; 44: 171–5

    CAS  Google Scholar 

  44. Carlstrom K, Brody S, Lunell NO, et al. Dehydroepiandrosterone sulfate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 1988; 10: 297–306

    Article  PubMed  CAS  Google Scholar 

  45. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 1986; 15: 213–28

    Article  PubMed  CAS  Google Scholar 

  46. Parker LN. Control of adrenal androgen secretion. Endocrinol Metab Clin N Am 1991; 20: 401–21

    CAS  Google Scholar 

  47. Carr BR. Disorders of ovaries and female reproductive tract. In: Wilson JD, Foster DW, editors. Williams Textbook of Endocrinology, 8th ed. Philadelphia: W.B. Saunders Co, 1992: 733–98

    Google Scholar 

  48. Homo-Delarche F, Fitzpatrick F, Christefe N, et al. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Molec Biol 1991; 40: 619–37

    Article  PubMed  CAS  Google Scholar 

  49. Nasatzky E, Schwartz Z, Saskotine WA, et al. Evidence for receptor specific for estradiol and testosterone in chondrocyte cultures. Connective Tissue Res 1994; 30: 277–94

    Article  CAS  Google Scholar 

  50. Kim-Schulze S, McGowan KA, Hubchalk SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996; 94(6): 1402–7

    Article  PubMed  CAS  Google Scholar 

  51. Liu SHL, al-Sheikh R, Panossian V, et al. Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Ortho Res 1996 14: 526–33

    Article  CAS  Google Scholar 

  52. Suzuki T, Suzuki N, Engleman EG, et al. Low serum levels of DHEA may cause deficient IL-2 production by lymphocytes in patients with SLE. Clin Exp Immunol 1995; 99: 251–5

    Article  PubMed  CAS  Google Scholar 

  53. Khalkhali-Ellis Z, Seftor EA, Nieva DRC, et al. Recepto mediated sex hormone regulation of synoviocyte function in vitro: implications in rheumatoid arthritis. J Rheumatol. In press

  54. Athreya UH, Rafferty JH, Sehgal GS, et al. Adenohypophyseal and sex hormone pediatric rheumatic diseases. J Rheumatol 1993; 20: 725–30

    PubMed  CAS  Google Scholar 

  55. Lawrence JM, Ghosh S, Patrick P, et al. Prolactin deficiency in juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1992; 35 Suppl.: 135

    Google Scholar 

  56. McMurray RW, Allen SH, Pepmueller PH, et al. Elevated levels of prolactin in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity. J Rheumatol 1995; 22: 1577–80

    PubMed  CAS  Google Scholar 

  57. Khalkhali-Ellis Z, Moore TL, Hendrix MJC. Reduced levels of testosterone and dehydroepiandrosterone sulphate in the synovial fluid of JRA patients correlates with disease progression. Clin Exp Rheumatoid 1998; 16: 753–6

    CAS  Google Scholar 

  58. Cassidy TL, Pelly RE. Juvenile rheumatoid arthritis. In: Cassidy JT, Pelly RE, editors. Textbook of paediatric rheumatology. 3rd ed. Philadelphia: W.B. Saunders Co., 1989: 1289–311

    Google Scholar 

  59. Terkeltaub R, Esdaile J, Decary F, et al. A clinical study of older age rheumatoid arthritis with comparison to younger onset group. J Rheumatol 1983; 10: 418–24

    PubMed  CAS  Google Scholar 

  60. Rudge SR, Kowanko IC, Drury PL. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. Ann Rheum Dis 1983 42: 425–30

    Article  PubMed  CAS  Google Scholar 

  61. Wingrave S, Kay S. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Lancet 1978; I: 569–71

    Google Scholar 

  62. Persellin RH. The effect of pregnancy of rheumatoid arthritis. Bull Rheum 1976-77; 27(9): 922–7

    Google Scholar 

  63. Cutolo M, Balleari E, Giusti M, et al. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol 1986; 13: 1019–23

    PubMed  CAS  Google Scholar 

  64. Sambrook PN, Eisman JA, Champion GD, et al. Sex hormone status and osteoporosis in post-M women with RA. Arthritis Rheum 1988; 8: 973–8

    Article  Google Scholar 

  65. Cutolo M, Balleari E, Giusti M, et al. Sex hormone status of male patients with rheumatoid arthritis: evidence for low serum concentrations of T at baseline and after human chorionic gonadotropin estimulation. Arthritis Rheum 1988; 31: 1314–17

    Article  PubMed  CAS  Google Scholar 

  66. Cutolo M, Foppiani L, Prete C, et al. Hypothalamic-pituatry-adrenal axis in premenopausal rheumatoid arthritis patients not treated with glucocorticoids. J Rheumatol 1999; 26: 282–8

    PubMed  CAS  Google Scholar 

  67. Arnalich F, Bento-Urbina S, GonzalezGancedo P, et al. Elevation des androgen plasmatiques chez les femmes menopausees atteintes de polyarthrite rheumatoide. Rev Rheum Mal Osteo Articul 1990; 57: 509–12

    CAS  Google Scholar 

  68. Mirone L, Altomonte L, D’Agostino P, et al. A study of serum androgen and Cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity. Clin Rheumatol 1996; 15: 15–19

    Article  PubMed  CAS  Google Scholar 

  69. Feher GK, Feher T, Meretey K. Interrelationship between the immunological and steroid hormone parameters in rheumatoid arthritis. Exp Clin Endocrinol 1986; 87: 38–42

    Article  PubMed  CAS  Google Scholar 

  70. Spector TD, Perry LA, Tubb G, et al. Low testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 65–8

    Article  PubMed  CAS  Google Scholar 

  71. Ollier W, Spector T, Gilman A, et al. Are certain HLA haplo-types responsible for low testosterone levels in males? Dis Markers 1989; 7: 139–43

    PubMed  CAS  Google Scholar 

  72. Hedman M, Nilsson E, De La Torre B. Low blood and synovial fluid levels of sulphoconjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 1992; 10: 25–30

    PubMed  CAS  Google Scholar 

  73. Bijlsma JWJ, Thijssen JHH, Huber-Bruning O, et al. Sex hormones in active rheumatoid arthritis. Proceedings of the XVI International Congress of Rheumatology. 1985 May 19–25; Sydney; 683: 371–5

    Google Scholar 

  74. Hall GM, Perry LA, Spector TD. Depressed levels of DHEAS in postmenopausal women with RA but no relation with axial bone density. Annals Rheum Dis 1993; 52: 211–4

    Article  CAS  Google Scholar 

  75. Deighton GM, Watson MJ, Walker DJ. Sex hormones in postmenopausal HLA-identical RA discordant sibling pairs. J Rheumatol 1992; 19: 1663–7

    PubMed  CAS  Google Scholar 

  76. Dougados M, Nahoul K, Benhamou L, et al. Androgen plasma levels in female RA patients. Arthritis Rheum 1983; 26: 935–6

    Article  PubMed  CAS  Google Scholar 

  77. Feher GK, Feher T. Plasama DHEA, DHEA-S and androsterone sulfate levels and their interaction with plasma proteins in rheumatoid arthritis. Exp Clin Endocrinol 1984; 84: 197–202

    Article  PubMed  CAS  Google Scholar 

  78. Nagy E, Chalmer IM, Baragan FO, et al. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991; 18: 1662–8

    PubMed  CAS  Google Scholar 

  79. Mateo L, Nolla JM, Bonnin MR, et al. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol 1998; 25: 2077–82

    PubMed  CAS  Google Scholar 

  80. Chikanza IC, Petrou P, Chrousos G, et al. Excessive and disregulated secretion of prolactin in rheumatoid arthritis. Immunopathogenic and therapeutic implications. Br J Rheumatol 1993; 32: 445–8

    Article  PubMed  CAS  Google Scholar 

  81. Gordon D, Beastall GH, Thomson JA, et al. Androgenic status and sexual function in males with RA and ankylosing spondylitis. Q J Med 1986; 60 (231): 671–9

    Google Scholar 

  82. Gudbjornsson B, Skogseid B, Oberg K, et al. Intact adrenocorticotrophic hormone secretion but impaired corticol response in patients with RA: effect of glucocorticoids. J Rheumatol 1996; 23: 577–81

    Google Scholar 

  83. Masi AT, Chatterton RT, Aldag JC. Perturbation of HPAaxis and anabolic androgen function in RA: an Odyssey of hormonal relationship to the disease. Ann NY Acad Science 1999; 876: 53–62

    Article  CAS  Google Scholar 

  84. Heikkila R, Aho K, Heliovaara M, et al. Serum androgen-anabolic hormones and the risk of developing RA. Ann Rhem Dis 1998; 57: 281–5

    Article  CAS  Google Scholar 

  85. Bjilsma JWJ, Cutolo M, Masi AT, et al. Neuroendocrine immune basis of the rheumatic diseases. Immunol Today 1999; 20: 298–301

    Article  Google Scholar 

  86. Ishmael WK, Helbaum A, Kuhn JF, et al. The effect of certain steroid compounds on various manifestations of rheumatoid arthritis. J Okla State Med Assoc 1942; 42: 434–7

    Google Scholar 

  87. Bird HA, Birkinshaw L, Pearson D, et al. A control trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women. Ann Rheum Dis 1987; 46: 237–43

    Article  PubMed  CAS  Google Scholar 

  88. Hall GM, Daniels M, Huskisson EC, et al. Arandomized control trial of the effect of hormone replacement therapy on disease activity in post menopausal rheumatoid arthritis. Ann Rheum Dis 1994; 53: 112–6

    Article  PubMed  CAS  Google Scholar 

  89. Hall GM, Larbre JP, Spector TD, et al. A randomized trial of testosterone therapy in males with RA. Br J Rheumatol 1996 35: 568–73

    Article  PubMed  CAS  Google Scholar 

  90. Cutolo M, Ballieri E, Giusti M, et al. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1–5

    Article  PubMed  CAS  Google Scholar 

  91. Booij A, Biewenga-Booij CM, Huber-Bruning O, et al. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 1996; 55: 811–5

    Article  CAS  Google Scholar 

  92. Van den Brink HR, van Everdingen A, van Wijk MJG, et al. Adjuvant estrogen therapy has no effect on disease activity in postmenopausal women with active rheumatoid arthritis. Arthritis Rheum 1992 35: S202

    Google Scholar 

  93. Robinzon B, Cutolo M. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids? Rheumatology 1999; 38: 488–95

    Article  PubMed  CAS  Google Scholar 

  94. Kimura M, Tanaka S, Yamada Y, et al. Dehydroepiandrosterone decreases TNF-α and restores insulin sensitivity: independent effects from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology 1998; 139: 3249–53

    Article  PubMed  CAS  Google Scholar 

  95. Feldman HA, Johannes CB, McKinlay JB, et al. Low dehydroepiandrosterone sulfate and heart disease in middle aged men: cross-sectional results from the Massachusets Male Aging Study. Ann Epidemiol 1998; 8: 217–28

    Article  PubMed  CAS  Google Scholar 

  96. Vogiatzi MG, Boeck MA, Vlachopapadopoulou E, et al. Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance. Metab Clin Exp 1996; 45: 1011–5

    Article  PubMed  CAS  Google Scholar 

  97. Johannes CB, Stellato RK, Feldman HA, et al. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate to cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women’s Health Study. J Clin Epidemiol 1999; 52: 95–103

    Article  PubMed  CAS  Google Scholar 

  98. Derksen RH. Dehydroepiandrosterone and systemic lupus erythematosus. Semin Arthritis Rheum 1998; 27: 335–47

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy and Cell Biology, The University of Iowa, Iowa City, IA, 52242, USA

    Zhila Khalkhali-Ellis & Mary JC Hendrix

  2. Departments of Paediatrics and Internal Medicine, Division of Rheumatology, St Louis University, St Louis, Missouri, USA

    Terry L Moore

Authors
  1. Zhila Khalkhali-Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terry L Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary JC Hendrix
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhila Khalkhali-Ellis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khalkhali-Ellis, Z., Moore, T.L. & Hendrix, M.J. Could Hormones Make a Difference in the Treatment of Juvenile Rheumatoid Arthritis?. BioDrugs 13, 77–86 (2000). https://doi.org/10.2165/00063030-200013020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-200013020-00001

Keywords

Search

Navigation